Why the study?
Clinical application of doxorubicin is restricted by multiple organ toxicity, including nephrotoxicity, prompting investigation into the protective effects and mechanisms of dexrazoxane against doxorubicin-induced nephropathy.
Does dexrazoxane pretreatment prevent doxorubicin-induced nephropathy in rats?
Population
Male Sprague Dawley rats receiving doxorubicin
Comparison
Dexrazoxane pretreatment vs doxorubicin alone
Design
Preclinical animal study
Follow-up
5 consecutive weeks
Authors
Loading...
Does not support clinical use; leaves open whether dexrazoxane prevents doxorubicin nephropathy in humans.
Does dexrazoxane pretreatment prevent doxorubicin-induced nephropathy in rats?
Dexrazoxane pretreatment protects against doxorubicin-induced nephropathy in a rat model by inhibiting lipid peroxidation, apoptosis, and fibrosis.
Hu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: